BioMarck Pharmaceuticals Initiates Phase 2 Clinical Study – Carolina Newswire (press release)
BioMarck Pharmaceuticals Initiates Phase 2 Clinical Study Carolina Newswire (press release), NC - Jun 30, 2008 BIO-11006 potentially represents a significant advance in the treatment of COPD due to its novel dual mechanism of action: inhibition of both mucus ... |